m1A调节器介导的甲基化修饰和基因特征及其在多发性骨髓瘤的预后价值
Jiaqi Fu1, Xingjun Han2, Wei Gao3
1Department of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China.
Experimental and therapeutic medicine
|December 3, 2024
概括
N1-甲基氨酸 (m1A) RNA修饰及其调节剂是理解多发性骨髓瘤 (MM) 的关键. m1A调节者的高表达表明预后有利,而YTHDF2则是MM的潜在治疗标.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 在瘤学瘤学.
背景情况:
- N1-甲基氨酸 (m1A) 是一种重要的RNA修饰物,参与各种生物过程.
- 在多发性骨髓瘤 (MM) 病原发生过程中,m1A调控修饰的作用尚不清楚.
研究的目的:
- 研究MM中的m1A调节者的表达模式.
- 评估MM患者m1A修饰模式的预后价值.
- 探索MM中含有YTH域的家族蛋白2 (YTHDF2) 的功能作用.
主要方法:
- 在正常血和MM骨髓血细胞中分析m1A调节者的mRNA表达.
- 无监督聚类和生存分析以确定m1A修饰模式.
- 构建和验证一个m1A分数模型.
- 在体外测试 (免疫组织化学,CCK-8,流细胞计,点点) 来评估YTHDF2的功能.
- 生物信息学分析预测YTHDF2下游目标和途径.
主要成果:
- 在MM中发现了7种差异表达的m1A调节剂.
- 发现了三种不同的m1A修饰模式,其中B集群与预后不佳有关.
- 高的m1A得分与临床益处和改善的治疗反应相关.
- 高YTHDF2表达与低生存率有关,并促进了MM细胞的增殖.
- YTHDF2的过度表达增加了m1A水平,其下游基因在特定的信号通路中得到了丰富.
结论:
- m1A调节器在MM中表现出显著的预后价值.
- YTHDF2是MM的潜在治疗点,因为它在扩散中的作用和与预后不佳的关联.
- m1A评分模型可以预测MM患者的临床益处和治疗反应.
相关概念视频
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Histone Modification
13.0K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.0K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


